Thapsigargin has a dual, concentration-dependent effect on adrenal glomerulosa cells, acting as a Ca2+ store depleter at low doses and a voltage-activated Ca2+ channel blocker at high doses.
Answers are grounded in this paper and cite their sources.
Thapsigargin's dual Ca2+ actions in adrenal cells warrant dose-specific experimental caution; leaves open aldosterone-related cardiovascular research applications.
Thapsigargin, an inhibitor of the microsomal Ca2+ pumps, has been extensively used to study the intracellular Ca2+ pool participating in the generation of the agonist-induced Ca2+ signal in various cell types. A dual effect of this agent was observed in bovine adrenal zona glomerulosa cells. At nanomolar concentrations, thapsigargin stimulated a sustained Ca2+ influx, probably resulting from Ca(2+)-store depletion. In contrast, when added at micromolar concentrations, thapsigargin prevented the rise in cytosolic free Ca2+ concentration ([Ca2+]c) induced by K+. This inhibitory effect of thapsigargin on voltage-activated Ca2+ channels was confirmed by measuring Ba2+ currents by the patch-clamp technique. Both low-threshold (T-type) and high-threshold (L-type) Ca2+ channels were affected by micromolar concentrations of thapsigargin. Analysis of the current-voltage relationship for T-type channels revealed that thapsigargin did not modify the sensitivity of these channels to the voltage, but decreased the maximal current flowing through the channels. In conclusion, thapsigargin appears to exert a dual effect on adrenal glomerulosa cells. At lower concentrations, this agent induces a sustained Ca2+ entry, whereas at higher concentrations it decreases [Ca2+]c by blocking voltage-activated Ca2+ channels.
No takes yet. Share an insight, caveat, or question.
Rossier et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: